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Abstract 
Objective: Bipolar disorders are often not recognized and undertreated. 
The diagnosis of current or past episodes of hypomania is of importance 
in order to increase diagnostic certainty. The Hypomania Checklist-32 
is a self-applied questionnaire aimed at recognizing these episodes. As 
part of the international collaborative effort to develop multi-lingual 
versions of the Hypomania Checklist-32, we aimed to validate the 
Brazilian version and to compare its psychometric properties with 
those of the Mood Disorder Questionnaire. Method: Adult outpatients 
with bipolar disorder I (n = 37), bipolar disorder II (n = 44) and major 
depressive disorder (n = 42) of a specialized mood disorder unit were 
diagnosed according to DSM-IV-TR using a modified version of the 
SCID. We analyzed the internal consistency and discriminative ability of 
the Hypomania Checklist-32 Brazilian version in relation to the Mood 
Disorder Questionnaire. Results: The internal consistency of the Brazilian 
Hypomania Checklist-32, analyzed using Cronbach’s alpha coefficient, 
was 0.86. A score of 18 or higher in the Hypomania Checklist-32 Brazilian 
version distinguished between bipolar disorder and major depressive 
disorder, with a sensitivity of 0.75 and a specificity of 0.58, compared 
to 0.70 and 0.58, respectively, for the Mood Disorder Questionnaire 
(score ≥ 7). The Hypomania Checklist-32 Brazilian version showed a 
dual factor structure characterized by “active/elated” and “risk-taking/
irritable” items. Hence, the Hypomania Checklist-32 Brazilian version 
was found to have a higher sensitivity but the same specificity as the 
Mood Disorder Questionnaire. Conclusion: The Brazilian version of 
the Hypomania Checklist-32 has adequate psychometric properties and 
helps discriminating bipolar disorder from major depressive disorder (but 
not bipolar disorder I from bipolar disorder II) with good sensitivity and 
specificity indices, similar to those of the Mood Disorder Questionnaire.
Descriptors: Questionnaire; Major depressive disorder; Bipolar disorder; 
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Resumo
Objetivo: O transtorno bipolar muitas vezes não é reconhecido e deixa de ser 
tratado adequadamente. O diagnóstico de episódios atuais ou passados é importante, 
a fim de aumentar a certeza diagnóstica. O Questionário de Autoavaliação 
de Hipomania-32 é um questionário autoaplicável para o rastreamento desses 
episódios. Como parte do desenvolvimento em vários idiomas do Questionário de 
Autoavaliação de Hipomania-32, nós objetivamos validar a versão brasileira e 
comparar suas propriedades psicométricas com o Questionário de Transtornos do 
Humor. Método: Em uma unidade especializada em transtornos do humor foram 
selecionados pacientes ambulatoriais adultos com transtorno bipolar I (n = 37), 
transtorno bipolar II (N = 44) e transtorno depressivo maior (N = 42) de acordo 
com a DSM-IV-TR, utilizando uma versão modificada do SCID. Analisou-se a 
consistência interna e capacidade discriminativa do Questionário de Autoavaliação 
de Hipomania-32 versão brasileira comparada ao Questionário de Transtornos do 
Humor. Resultados: A consistência interna do Questionário de Autoavaliação de 
Hipomania-32 versão brasileira é boa, com alfa de Cronbach 0,86. Um escore de 
18 ou mais no Questionário de Autoavaliação de Hipomania-32 versão brasileira 
distingue entre o transtorno bipolar e o transtorno depressivo maior com uma 
sensibilidade de 0,75 e especificidade de 0,58, e para o Questionário de Transtornos 
do Humor, para um escore de 7 ou mais, de 0,70 e 0,58, respectivamente. 
O Questionário de Autoavaliação de Hipomania-32 mostrou uma estrutura 
caracterizada pela predominância de dois fatores (ativação/elação e irritabilidade/
correr riscos). Assim, o Questionário de Autoavaliação de Hipomania-32 versão 
brasileira tem maior sensibilidade, mas a mesma especificidade que o Questionário 
de Transtornos do Humor. Conclusão: A versão brasileira do Questionário de 
Autoavaliação de Hipomania-32 possui propriedades psicométricas adequadas e 
ajuda a discriminar o transtorno bipolar do transtorno depressivo maior (mas não 
transtorno bipolar I de transtorno bipolar II), com boa sensibilidade e especificidade, 
semelhante ao Questionário de Transtornos do Humor.
Descritores: Questionário; Transtorno depressivo maior; Transtorno bipolar; 
Diagnóstico; Psicometria  
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Introduction
Bipolar disorder (BD) is a chronic psychiatric illness that is often 
misdiagnosed.1 Indeed, it may take an average of 10 years from 
symptom onset to recognition and treatment.2,3 It is a burdensome 
disorder, and even its subsyndromal forms negatively impact 
social and functional outcomes in adolescents.4,5 Accordingly, 
the identification of patients within the broad bipolar spectrum 
is of great clinical importance. Consequences of misdiagnosis 
include worsening of the disease, iatrogenic treatment with 
antidepressants, increased risk of suicide, alcoholism, drug 
addiction, risk of contracting sexually transmitted diseases (mainly 
AIDS), and litigations.6,7 
Bipolar disorder type II (BD-II) is a common disorder, affecting 
around 3-5% of the adult population worldwide, with estimates of 
up to 11% for bipolar spectrum disorders.8 In Brazil, the lifetime 
prevalence is 8.3% for the bipolar spectrum.9
Recognition of past episodes of hypomania is pivotal for the 
diagnosis, although depression is the typically presenting feature of 
the illness. The under-recognition of hypomania leads to a significant 
rate of misdiagnosis, with consequent mismanagement, i.e., 
treatment of BD as a unipolar disorder.10 Because hypomania is often 
not perceived by patients as pathological, it is not common for them 
to spontaneously report it to clinicians.11  Furthermore, clinicians 
often do not directly inquire about hypomania if patients are seen 
during episodes of depression,12 despite evidence showing that from 
30% to 60% of outpatients with BD are initially considered to be 
unipolar.13  This is of great importance, since  the long term outcome 
of BD can be modified by early identification and treatment.14 
Accordingly, the recognition of hypomania may require more 
detailed assessments than currently available through structured 
diagnostic interviews, such as the diagnostic criteria of the DSM-
IV.15 Indeed, these interviews may be less valid than previously 
believed.12 The DSM-IV diagnostic criteria have high specificity 
but low sensitivity for the diagnosis of hypomania. It has been 
proposed that focusing on specific symptoms (e.g., activation), 
as well as accepting shorter durations of episodes, may improve 
the recognition of bipolar disorder.4 For these reasons, diagnostic 
tools for hypomania and BD-II are necessary. Several screening 
instruments have been developed for this purpose. Some of them 
assess trait-like features (e.g., Hypomanic Personality Scale),16 and 
are better understood as assessing risk factors for future disorders.12 
These scales assess personality traits rather than the episodic nature 
of hypomania, and do not evaluate possible changes in affect, 
cognition, and behavior in bipolar patients.17 Other self-report 
measures have not been proposed as screening instruments, but 
assess symptoms, such as the Self-Report Inventory for Mania18 
and the Brief Bipolar Disorder Scale.19
The Hypomania Checklist-32 (HCL-32) is an internationally 
validated self-applied questionnaire.20-25 The primary goal of the 
authors of the HCL-32 is to identify hypomanic components in 
patients with depression, in order to facilitate the diagnosis of BD-
II. A secondary goal is the development of shorter multi-lingual 
versions with established cut-off scores for hypomania.11 
Accordingly, the aim of this study was to develop a Brazilian 
version of the HCL-32 (HCL-32 VB), as well as to describe its 
psychometric characteristics for use in the clinical practice. We 
also aimed to determine a threshold score with good sensitivity 
and specificity to detect hypomania. In addition, we contrasted the 
HCL-32 VB with the Mood Disorder Questionnaire (MDQ), a 
screening instrument largely used for improving the identification 
of BD.26 Its English version was shown to have a sensitivity of 
73% and a specificity of 90% for a sample consisting mostly of 
BD-I patients. In the development study, the MDQ was more 
efficient in identifying BD-I than BD-II.27 Because the HCL-32 
has a better focus on hypomanic symptoms, we hypothesized that 
it could be more adequate to identify bipolarity types I and II.
Method
The study was conducted at the Mood Disorders Unit 
(GRUDA) of the Department and Institute of Psychiatry of the 
School of Medicine, Universidade de São Paulo, Brazil. The study 
was approved by the Institutional Ethics Committee and consent 
forms were obtained from all participants. 
1. Subjects  
BD-I, BD-II, and major depressive disorder (MDD) outpatients 
of both genders (N = 150), aged 18 to 65 years, were selected 
according to SCID-I/P – DSM-IV diagnoses. Participants 
were typically chronic and difficult to treat. We included only 
symptomatic individuals (mania, hypomania, depression), treated 
or not. Exclusion criteria included uncompensated substance abuse 
or dependence (except nicotine) over the previous three months, 
organic mental disorders, and incapacity to understand the 
questionnaire. Volunteers were assessed by the primary investigator 
using the SCID-I/P.28 
2. Instruments 
The HCL-32 consists of 32 yes/no questions. It is a self-applied 
questionnaire for the assessment of hypomania that investigates 
the presence of a variety of symptoms.11 Participants are requested 
to focus on ‘‘the ‘high’ periods’’ and to indicate whether specific 
thoughts or emotions were present during this state (including 
low-threshold symptoms such as ‘‘making jokes’’ and ‘‘I am less 
shy and inhibited’’ or ‘‘I am more flirtatious and/or am sexually 
more active’’). In addition, the HCL-32 includes 8 severity and 
functional impact items related to the duration of the episodes 
and to positive and negative consequences across different areas. 
Participants are asked to rate the impact on family life, social life, 
school, and leisure, as ‘‘positive’’, ‘‘no impact’’, or ‘‘negative.’’ In 
addition, other people’s reactions and comments (positive, neutral 
or negative) about such episodes are assessed. 
The MDQ is a self-rating screening questionnaire for BD-I 
and II, with questions related to hypomania, validated for use in 
psychiatric practice2 and in the general population.29 It consists of 
13 questions (yes/no) evaluating mood, self-confidence, energy, 
sociability, interest in sex, and other behaviors. Two additional 
questions explore the concomitance of symptoms during any given 
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period, as well as the severity of the functional impairment caused 
by the symptoms. Disability is rated from “no consequences” to 
“severe consequences”.29 The MDQ is considered positive when 
individuals respond “yes” to at least 7 of the 13 items, have at least 
2 symptoms occurring simultaneously, and are at least moderately 
impacted. The Brazilian version of the MDQ is in process of 
validation by the authors.
The SCID-I/P is the standardized semi-structured clinical 
interview which provides diagnoses according to the DSM-IV-
TR.15 It was developed by the American Psychiatric Association 
and is designed for use by clinicians with experience in assessing 
psychopathology and managing patients. According to it, the 
diagnosis of hypomania requires at least four days of mood 
change with euphoria and/or irritability and is a prerequisite for 
subsequent questioning on manic symptoms. The present study 
imposed no minimum time limit for hypomania diagnosis, given 
that the four-day period is in itself arbitrary.21 All mania-related 
questions were asked, even when patients denied mood changes. 
When this happened, the question on irritable and/or manic mood 
was asked again at the end of the evaluation in order to increase 
the detection of bipolarity.25  
3. Procedures
The original version of the HCL-32 was translated and 
adapted to Brazilian Portuguese according to the World Health 
Organization instrument translation protocol.30 The first draft of 
the Brazilian version was translated by the authors and reviewed 
by experts in mood disorders, as well as by a Brazilian Portuguese 
teacher. It was then back-translated by an English (American) 
teacher. The same procedure was applied for the MDQ. All eligible 
patients received instructions to complete both the HCL-32 VB 
and the MDQ. 
4. Statistical analysis 
Data were entered in summary tables and descriptive statistics. 
Demographic variables (except gender) were analyzed using 
analysis of variance (ANOVA) after confirmation of normality and 
homogeneity of variances. Data related to gender were analyzed 
using the chi square test, since each frequency was > 5. In the 
absence of a normal distribution, we used a nonparametric Mann-
Whitney U-test to compare the mean number of positive responses 
to the HCL-32 BV. To analyze the consistency of the 32 items, we 
used principal component factor analysis with subsequent varimax 
rotation. The number of factors was decided in accordance with 
the Scree test and Monte Carlo Parallel Analysis. Subscale scores 
for each factor were obtained by summing all items that loaded 
higher than 0.40 on the corresponding factor. Internal consistency 
was analyzed using Cronbach’s alpha coefficient for the total 
HCL-32 VB and its subscales. Receiver operating characteristic 
(ROC) analysis was conducted to distinguish MDD from 
bipolar patients. Threshold scores in the HCL-32 VB for bipolar 
patients were calculated. The area under the ROC curve (AUC) 
was determined as a measure of discriminant predictive value. 
Associations between the current mental state (HCL-32) and 
current episode type (DSM-IV) were evaluated using Spearman’s 
correlation. Two-tailed tests with a probability (p-value) < 0.05 
were considered significant. All statistical analyses were performed 
using the Statistical Package for the Social Sciences (SPSS).31 
Results
1. Sample size and demographic variables
The HCL-32 VB was completed by 150 patients. The sample 
size was established so that the total number of patients was 
approximately five times the number of items32 in the HCL-32, 
and adequately powered (0.944) to conduct a factor analysis 
and assess the sensitivity and specificity of the instrument. For 
an estimated power of 0.85, we would need 31 patients in each 
diagnosis. Of 150 individuals enrolled, 27 were excluded; 11 
due to substance abuse and 16 due to inability to complete the 
questionnaires properly. Such inability was mostly related to their 
low educational level and not to cognitive impairment associated 
with mania, hypomania or depression. Accordingly, our final 
sample comprised 81 patients with BD (37 BD-I; 44 BD-II) and 
42 with MDD. No significant differences were found in relation 
to age or gender (Table 1).
2. Translation and adaptation
The Brazilian version of the HCL-32 was approved by the 
authors of the original version and was named HCL-32 VB 
(Appendix 1 – see at www.scielo.br/rbp). The Brazilian version 
of the MDQ was named MDQ VB (Appendix 2 – see at  www.
scielo.br/rbp). 
Feasibility was described as the percentage of patients (n = 12) 
who did not complete the entire questionnaire (8% left at least 
one question unanswered). Internal consistency was high, with a 
Cronbach’s alpha coefficient of 0.86 for the entire HCL-32 VB, 
indicating that the items of the questionnaire were sufficiently 
homogeneous. The exclusion of individual items did not affect 
Cronbach’s alpha. The factor analysis resulted in 9 factors with 
eigenvalues > 1, explaining 61.6% of the total variance. According 
to the Scree test and Monte Carlo Parallel Analysis, a 2-factor 
solution was preferred. 
The first factor, with an eigenvalue of 6.79, explained 21.2% 
of the variance and comprised 20 items (Table 2). This subscale 
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area under the curve of the HCL-32 BV was 0.702, indicating 
a good discriminant ability (Figure 1). The best combination of 
sensitivity (0.75) and specificity (0.58) was established with a score 
above 18, which discriminates between BD and MDD patients. 
To compare the discriminant properties of the HCL-32 VB and 
the MDQ VB, we calculated the sensitivity and specificity of both 
questionnaires. The ROC curve of the MDQ VB is shown in 
Figure 2. The HCL-32 VB had a sensitivity of 0.75 and specificity 
of 0.58. The MDQ VB had a sensitivity of 0.70 and specificity 
of 0.58. Hence, the HCL-32 VB showed a higher sensitivity but 
the same specificity as the MDQ VB. Spearman’s correlation was 
consisted of questions related to “active/elated” symptoms. The 
second factor, with an eigenvalue of 3.31 (10.34% of the variance), 
comprised 7 items and included questions associated with 
“irritable/risk-taking” items. For individual items, a factor loading 
≥ 0.40 suggested significant item factors. The factor structure 
resembled that obtained for other samples of non-clinical subjects 
and patients with affective disorders in previous studies.11,20,22  
Individuals with BD had the highest HCL-32 VB scores. The 
mean number of affirmative responses to the list of symptoms 
was significantly different according to diagnosis. We analyzed 
the scale’s discrimination of BD through the ROC curve. The 
Brazilian version of HCL-32 vs. MDQ
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used to correlate current mood state and the HCL-32 total and 
subscale scores. There was no impact on the self-assessment of 
hypomanic symptoms (p = 0.861). Significant differences were 
found for the two subscales between BD-II and MDD, but not 
between BD-I and BD-II, and no differences were found between 
BD-I and MDD when using the subscale of the first dimension, 
composed of 20 items (Table 3).
Discussion 
The recognition of hypomania is pivotal for the diagnosis of 
BD-II. Because hypomania is often not perceived by patients as 
pathological, it is not common for them to spontaneously report 
it to clinicians. The recognition of hypomania may require more 
subtle inquiries than those present in currently available structured 
diagnostic interviews, such as those based on DSM-IV criteria. 
Instruments assessing hypomania may be of importance for the 
clinical practice in Portuguese-speaking countries like Brazil.
Our study included patients with BD-I, BD-II and MDD. 
We found that the HCL-32 VB had good sensitivity (0.75) and 
specificity (0.58) with a cut-off score of 18, meaning that 18 
affirmative answers have good discriminatory power to distinguish 
BD from unipolar disorder. This differs from the cut-off point 
(14-15) found in studies conducted in other languages.4,21-24 These 
differences can be explained by the fact that the sample was derived 
from a tertiary care facility, characterized by patients with greater 
chronicity and more resistant to treatment. The criterion of 18 
affirmative responses to hypomanic symptoms in the HCL-32 
VB is sensitive enough to alert healthcare providers about the 
presence of bipolar disorder. Once aware, clinicians should proceed 
to a more detailed psychiatric assessment in order to establish a 
definitive diagnosis.
When compared with the MDQ (sensitivity = 0.70/specificity 
= 0.58), the HCL-32 VB and the HCL-32 are more sensitive 
to detect hypomanic symptoms. The patients enrolled in our 
study were symptomatic (mania or hypomania and depression). 
The correlation analysis showed no association between current 
mood state and self-assessment of hypomanic symptoms. Internal 
consistency (Cronbach’s alpha of 0.86) was high and similar 
to values found in the validation of the HCL-32 for other 
languages.11,20,22-24 It was comparable to other instruments such as 
the MDQ.26,29 This reliability is similar to values found in samples 
of remitted patients (Italy, Spain, and Sweden)11,20 and also in the 
general population (Germany and Sweden).33 This indicates stable 
psychometric properties, regardless of clinical status or cultural 
differences. 
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Conclusion
The HCL-32 is the first instrument developed for the self-
assessment of hypomanic symptoms in patients diagnosed with 
depression.35 The retrospective detection of hypomania is critical 
for the correct diagnosis and, hence, for the treatment of BD. 
The psychometric parameters of the HCL-32 VB suggest that it 
is useful for the detection of hypomania in patients with mood 
disorders. A cut-off of 18 showed the best trade-off between 
sensitivity and specificity values. For screening tools, high 
sensitivity should not be traded-off by high specificity.36
The HCL-32 VB may be useful for the identification of 
hypomania in Brazilian epidemiological and clinical settings, 
facilitating the early identification of patients within the 
bipolar spectrum. The HCL-32 VB is a brief, self-administered 
questionnaire of easy application and interpretation, which can 
be used in Portuguese-speaking patients.
The factor structure also resembled that obtained with other 
samples of patients with affective disorders in previous studies.11,20 
A single factor load responded for 21,2% of the total variance. 
There is a greater possibility of bipolarity when high scores are 
detected in two factors, such as increased activation/elation and 
irritability/risk-taking behavior. The first factor (increase in 
activity, energy, social contacts, verbal fluency, self-confidence, 
and communication) relates to activation/increase in energy, 
while the other factor is related to disinhibition, self-control, and 
ability to focus (irritability, inattention, difficulties with impulse 
control, and excessive spending). We confirmed the presence of 
these two factors and, therefore, high scores in these factors are 
suggestive of bipolarity. The presence of subsyndromal symptoms 
of hypomania, such as “wear more colorful and more extravagant 
clothes, or make more jokes”, increases the possibility of BD, but 
also of more false-positive results. 
An interesting finding of our study was the high proportion 
of patients with MDD (42.9%) who scored positive in 18 or 
more questions, which was similar to results obtained in the large 
international BRIDGE study (data not yet published referring to 
2729 subjects with major depressive episodes).33 This finding could 
be related to the fact that the sample was recruited among patients 
of a tertiary care facility, characterized by greater chronicity and 
treatment resistance, which can be considered as risk factors for 
bipolarity.1 When used in another sample with more severe mood 
disorders, the cut-off score of the HCL-32 was also higher, and 
even after accurate screening for recurrent MDD, almost 18% 
had manic symptoms at a level similar to that of BD patients.27 
Another possible explanation is that some symptoms of hypomania 
(soft bipolarity) may be present even in clinically undisputable 
“unipolar” patients.34 The DSM-IV criteria do not seem to 
distinguish the presence or absence of bipolarity. The diagnosis 
of hypomania is a key aspect in the diagnosis of BD, and this 
questionnaire provides a potential aid to clinicians. Its use may 
translate into earlier diagnosis and treatment. Further studies are 
needed to evaluate the cut-off for other samples of non-clinical 
subjects or patients with less severe affective disorders.
Limitations 
Although the parameters found for the HCL-32 VB were 
robust, further studies are needed to evaluate the concurrent and 
discriminant validity, and the factor structure of the instrument. 
Furthermore, our study reflects parameters assessed in a tertiary 
care setting. A comparison with similar samples, before the 
application in patients, should be performed in future studies, 
both for the HCL-32 VB and the MDQ. This pioneering study is 
proposed to establish initial points for validation. Further studies 
can complement the process of validation of the HCL-32 VB. 
Moreover, other psychometric properties of the Brazilian version 
of the HCL-32, such as long-term test-retest reliability, remain 
to be evaluated in future research. 
Brazilian version of HCL-32 vs. MDQ
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